Introduction
============

The J wave is a defection immediately following the QRS complex of the surface electrocardiogram (ECG). When partially buried in the R wave, the J wave appears as J-point elevation or ST-segment elevation. Renewed interest in early repolarization arose after the discovery of an associated high risk of sudden cardiac death by ventricular fibrillation with both ST elevation in right precordial (V1--V3)[@b1-oajsm-2-033],[@b2-oajsm-2-033] and early repolarization in the inferior or mid to lateral precordial leads.[@b3-oajsm-2-033]--[@b5-oajsm-2-033]

Conflicting evidence exists on prevalence and prognostic significance of the Brugada-type ECG pattern and early ventricular repolarization pattern (ERP), particularly when found by chance in an asymptomatic individual and in an ethnic population where epidemiological data are lacking. To our knowledge, no data regarding the prevalence of the Brugada-type ECG pattern and the ERP exist in the North African population. The aim of this study was to determine the frequencies of the Brugada-type ECG pattern and ERP and to evaluate ECG descriptors of ventricular repolarization in a population of Tunisian athletes.

Methods
=======

Subjects
--------

Over a 2-year period (2008--2009), resting 12-lead ECG recordings were analyzed from athletes (n = 540; 348 males; 100% white Arabs, aged 18.3 ± 2.4 years, height = 172 ± 12 cm, weight = 63.6 ± 12.3 kg) as part of their physical examination. They were routinely controlled in the Central Sports Medicine Centre of El Menzah in Tunisia. The studied athletes represented 14 disciplines. All those who entered this study had no evidence of organic heart disease as judged from clinical history and physical and echocardiographic examination.

A 12-lead ECG (at a paper speed of 25 mm/s and 1 mV/10 mm standard gain) was recorded from each subject with the same equipment by the same person.

Brugada-type ECG pattern was defined as Type 1, 2, or 3. The consensus report of the Study Group of the Molecular Basis of Arrhythmias laid down precise diagnostic criteria for the Brugada-type ECG pattern,[@b6-oajsm-2-033],[@b7-oajsm-2-033] recognizing three variants of the repolarization pattern in chest leads V1--V3 (Type 1, classical convex ST elevation of ≥2 mm; Type 2, J wave amplitude ≥2 mm with concave ST elevation ≥ 1 mm; and Type 3, J point elevation with the ST segment isoelectric or elevated by \<1 mm).

ERP was defined as elevation of the J point (QRS-ST junction) noted as either QRS slurring or notching ≥0.1 mV in more than two adjacent leads in the inferior leads (II, III, and aVF) and/or lateral leads (I, aVL, and V~4~ through V~6~).[@b3-oajsm-2-033]

PR intervals, P wave duration and amplitude, T wave amplitude, and QRS amplitude were measured on lead II. P wave, T wave and QRS axis were calculated from frontal leads. The maximum QRS duration was assessed in any of the measurable leads of each ECG. Mean RR interval was also measured.

The interval from the peak to the end of the T wave (T~peak~--T~end~) and the QT interval were measured on leads V2 or V3 and leads II or V5. The point of T wave offset was defined as the return to the baseline. T~peak~--T~end~/QT ratio was also calculated.

QT intervals were corrected for heart rate using Fridericia's \[QTc Fri = QT(RR)^−1/3^\] and Sagie-Framingham's \[QTcFr = QT + 0.154 (1000 -- RR)\] formulas.[@b8-oajsm-2-033],[@b9-oajsm-2-033]

All ECG measurements were performed separately by two independent investigators who were blinded to the clinical data of the patients. The interpreters of the ECGs assessed also Brugada-type ECG patterns and ERP simultaneously. The averages of the measurements of the two observers were used for comparisons. The diagnosis of Brugada-type ECG pattern or ERP was made only when both investigators agreed on the classification of the ECG abnormalities.

The population was subsequently divided into three groups: ERP group; Brugada-type ECG pattern group; and control subjects, without either ERP or Brugada type ECG pattern. Clinical and ECG parameters were described for each group and compared with control groups.

Statistical analysis
--------------------

The age, gender, and ECG findings of the cases were recorded with SPSS (version 12.0, SPSS, Inc, Chicago, IL). Values are expressed as the mean ± SD (standard deviation), n value, and percentage (%). Student's *t*-test for independent samples and the chi-squared test were used, when appropriate, comparing two different groups. Two-sided *P* \< 0.05 was considered significant. The study protocol was approved by the Ethics Committee of the Central Sports Medicine Centre of El Menzah in Tunisia.

Results
=======

Prevalence of the Brugada-type ECG pattern
------------------------------------------

Among 540 athletes, we found nine subjects (1.66%) with a Brugada-type ECG pattern. All the subjects with the Brugada-type ECG pattern had a saddleback-type ECG abnormality and were asymptomatic. Three (0.6%) had the Type 2 ([Figure 1](#f1-oajsm-2-033){ref-type="fig"}), and six (1.1%) had the Type 3. A Brugada-type ECG pattern was obtained in two females and in seven males. No female had the Type 2, and none of the athletes displayed both ERP and Brugada-type ECG pattern.

The mean age, mean body area, and mean systemic arterial pressure in Brugada-type ECG pattern athletes were respectively 19.3 ± 1.0 years, 1.77 ± 0.16 m², and 120 ± 18/74 ± 9 mmHg, that were similar to clinical control parameters. However, males are more prevalent in Brugada-type ECG pattern than control athletes (77.7% versus 58.9%; *P* \< 0.0001). Mean ECG parameters are summarized in [Table 1](#t1-oajsm-2-033){ref-type="table"}. Heart rate, PR interval, P wave duration and amplitude, T wave, P wave, QRS axis, QRS duration, QT intervals, corrected QT intervals, T~peak~--T~end~ intervals and T~peak~--T~end~/QT ratio in Brugada-type ECG pattern group were not statistically different among control athletes.

Prevalence of early ventricular repolarization pattern
------------------------------------------------------

A total of 119 ECGs (22%) were found to fulfill the criteria for ERP that was obtained in 98 males and in 21 females. Males are more prevalent in ERP than in control group (82.3% versus 58.9%; *P* \< 0.0001).

ERP was present in the inferior leads (II, III, aVF) in 37 patients (31.1%), in the lateral leads (I, aVL, V~4~--V~6~) in 71 patients (59.6%), and in both the inferior and lateral leads in 11 patients (9.2%) ([Figures 2A](#f2-oajsm-2-033){ref-type="fig"} and [2B](#f2-oajsm-2-033){ref-type="fig"}).

Weight and body area were significant, although only marginally higher in ERP athletes than in controls. Mean age, mean height, and systolic and diastolic blood pressure were similar between the two groups.

PR interval, P wave duration and amplitude, QRS, P wave, and T wave axis were similar between ERP group and controls. ERP athletes had lower heart rate, greater QRS and T wave amplitude, and a slightly but significantly shorter QRS duration than the controls.

The duration of the QT interval was longer in ERP athletes than in control athletes, but no difference was observed when the QT interval was corrected for heart rate ([Table 1](#t1-oajsm-2-033){ref-type="table"}). T~peak~--T~end~ intervals were longer in the ERP athletes than in control athletes. However, T~peak~--T~end~/QT ratio was not different between the two groups ([Table 1](#t1-oajsm-2-033){ref-type="table"}).

Discussion
==========

The frequency of Brugada-type ECG pattern and ERP were found to differ among ethnic groups. No data regarding the frequency of the J wave sign exist in North African populations.

Brugada-type ECG pattern
------------------------

Our results indicate that the frequency of the Brugada-type ECG pattern was 1.66% in athletes, with a saddleback-type ECG abnormality in all cases. Epidemiological data suggest that Brugada-type ECG pattern is ubiquitous, but it varies significantly among ethnic populations, higher in south-eastern Asian countries, an event possibly reflecting the geographical genetic distribution of the disease.[@b6-oajsm-2-033],[@b10-oajsm-2-033] Large epidemiological information has been reported from Asian,[@b11-oajsm-2-033]--[@b21-oajsm-2-033] European,[@b22-oajsm-2-033]--[@b30-oajsm-2-033] and American[@b31-oajsm-2-033]--[@b34-oajsm-2-033] populations, and the data available are difficult to compare because of differences in the diagnostic criteria applied, and differences in the characteristics of the populations selected (sex ratio, age, healthy subjects or tertiary hospital patients) ([Table 2](#t2-oajsm-2-033){ref-type="table"}).

In accordance with different studies,[@b23-oajsm-2-033],[@b25-oajsm-2-033],[@b30-oajsm-2-033] we did not document any person with Brugada Type 1 ECG pattern.

Considering the dynamic nature of the ECG features, the true incidence of Brugada-type ECG pattern might have been underestimated.[@b29-oajsm-2-033]

Only one previous study had evaluated the prevalence of Brugada-type ECG pattern in an athletic cohort of 155 males with a reported prevalence of 7.7%, with a Brugada Type 1 ECG pattern in all cases.[@b24-oajsm-2-033]

The disparities between the present study and the Bianco et al study[@b24-oajsm-2-033] may be explained by differences between the two study populations. Bianco et al have included only males, older (mean age of the population: 30.9 ± 10.1 years), and competitive athletes.[@b24-oajsm-2-033]

In southern Europe, Hermida et al[@b22-oajsm-2-033] found a high prevalence of concave ST-segment elevation in 1000 European men (6%) and a far lower prevalence of convex ST-segment elevation (0.1%). Monroe and Littman[@b31-oajsm-2-033] found 52 cases of the Brugada-type ECG among approximately 12,000 unselected noncardiac hospitalized patients. In their report, the convex pattern was present in only two cases. In adolescents and in school children, the frequency of Brugada-type ECG pattern was very low even in regions of Southeast Asia where the Brugada syndrome is endemic.[@b14-oajsm-2-033]--[@b16-oajsm-2-033] Yamakawa et al[@b14-oajsm-2-033] have demonstrated a tendency for the prevalence of Brugada-type ECG pattern to increase with age. In the present study, we did not evaluate the prognostic value of Brugada type ECG pattern. Previous studies have suggested that Brugada-type ECG pattern has a benign natural course, independent of the ethnic origin of the study population.[@b12-oajsm-2-033],[@b20-oajsm-2-033],[@b21-oajsm-2-033],[@b28-oajsm-2-033],[@b29-oajsm-2-033]

ERP
---

Of our healthy "young athletes", 22% had J-point elevation, a figure consistent with the 22%[@b35-oajsm-2-033] to 27%[@b37-oajsm-2-033] of young athletes with J-point elevation reported by others.[@b35-oajsm-2-033]--[@b37-oajsm-2-033] Bianco et al[@b24-oajsm-2-033] identified a higher ERP prevalence (89%) in their competitive athlete group (age 30.9 ± 10.1 years). The athletes included in our study and those described by Rosso et al[@b35-oajsm-2-033] were noncompetitive.

The ERP has long been considered to be a "benign" ECG manifestation that is seen more commonly in young healthy men and athletes.[@b37-oajsm-2-033]--[@b40-oajsm-2-033] No athletes with ERP, reported by Bianco et al[@b24-oajsm-2-033] had suffered from major ventricular arrhythmias from the time of the study (2001) onward to 2009.[@b40-oajsm-2-033] However, mounting evidence suggests that the ERP may be associated with a risk for ventricular fibrillation, depending on the location of ERP, magnitude of the J wave, and degree of ST elevation.[@b3-oajsm-2-033]--[@b5-oajsm-2-033],[@b41-oajsm-2-033],[@b42-oajsm-2-033]

Recently, Sinner et al[@b42-oajsm-2-033] have reported a high prevalence of ERP (13.1%) in a population-based cohort of middle-aged individuals (35--74 years). After a mean follow-up of 18.9 years, ERP was associated with about a 2--4-fold increased risk of cardiac mortality in individuals between 35 and 54 years. An inferior localization of ERP was associated with a particularly increased risk.[@b42-oajsm-2-033]

Heart rate was found to be lower in ERP subjects than in controls, as previously reported.[@b24-oajsm-2-033],[@b37-oajsm-2-033],[@b43-oajsm-2-033],[@b44-oajsm-2-033] A greater vagotonia in ERP subjects has been previously reported as a possible contributing factor.[@b37-oajsm-2-033],[@b43-oajsm-2-033] The distribution of J-point elevation in our study was similar to that described by Rosso et al.[@b35-oajsm-2-033] Athletes had more commonly J-point elevation in lateral leads (V4--V6, Type 1) than in the inferior leads (Type 2).

The QRS duration was significantly shorter in ERP athletes than in controls. This is in accordance with previously published data,[@b24-oajsm-2-033] but discordant with the Dilaveris et al study.[@b44-oajsm-2-033] Disparities may be explained by differences in the populations studied and possible differences in the level of physical conditioning.

In accordance with previous publications, mean QT duration was significantly higher in ERP athletes than in control athletes.[@b24-oajsm-2-033],[@b37-oajsm-2-033],[@b44-oajsm-2-033] However, corrected QT intervals were similar between these two groups, which is in accordance with the Mehta and Jain study[@b37-oajsm-2-033] but in contrast with other studies finding lower corrected QT in ERP subjects than in controls.[@b44-oajsm-2-033] T~peak~--T~end~ intervals were significantly higher in ERP than in control athletes. T~peak~--T~end~/QT ratio showed no difference between these two groups.

Study limitations
-----------------

First, considering the dynamic nature of the ECG features, the true prevalence of Brugada-type ECG pattern and ERP might have been underestimated in this study. Second, we have identified differences in QT duration on leads V2 and II, which may be explained by differences in the projection of the T-wave loop between the ECG leads, or may simply be due to inaccuracies in defining the end of the T wave. Third, the physical activity level depending on the corresponding disciplines was not evaluated. Therefore, possible association between the presence of ERP and the athlete discipline was not investigated. Finally, no follow-up was described to ERP and Brugada-type ECG pattern, so no prognostic value of these ECG patterns were available.

Conclusion
==========

The results indicate that the frequency of the Brugada-type ECG pattern and ERP were respectively 1.66% and 22% in athletes, being more prevalent in males. These results are similar to the findings of studies performed in European and American countries. ERP was associated with shorter QRS duration and longer T~peak~--T~end~ interval. Further population-based investigation is warranted to determine the prognostic value of the J-point elevation.
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![Type 2 Brugada-type ECG of an athlete demonstrates saddle-back type ST-segment elevation (\>1 mm) in lead V2.](oajsm-2-033Fig1){#f1-oajsm-2-033}

![Sample electrocardiograms from two athletes, demonstrating early ventricular repolarization (ERP)-type ECG. ERP defined as ≥1 mm elevation of the QRS--ST junction (J point) in either inferior leads (Type 2) (**A**) or inferior and lateral leads (Type 3) (**B**).](oajsm-2-033Fig2){#f2-oajsm-2-033}

###### 

Clinical and ECG parameters of study cohorts

  Parameter                           ERP group     Control group   Brugada-type ECG pattern group   *P*[a](#tfn1-oajsm-2-033){ref-type="table-fn"}
  ----------------------------------- ------------- --------------- -------------------------------- ------------------------------------------------
  N (%)                               119 (22%)     412 (76.3%)     9 (1.7%)                         
  Male gender (n, %)                  98, 82.3%     243, 58.9%      7, 77.7%                         0.000
  Age (years)                         18.2 ± 2.3    18.1 ± 2.9      19.3 ± 1                         0.6
  Body area (m²)                      1.78 ± 0.23   1.72 ± 0.19     1.77 ± 0.16                      0.009
  Weight (kg)                         66.7 ± 12.4   62.7 ± 12.1     65 ± 9.9                         0.002
  Height (cm)                         172.7 ± 19    171.6 ± 9       174.1 ± 7.9                      0.375
  Systolic BP (mmhg)                  116 ± 12      115 ± 11        120 ± 18                         0.81
  Diastolic BP (mmhg)                 70 ± 9        68 ± 10         74 ± 9                           0.136
  RR (ms)                             867 ± 157     781 ± 145       815 ± 218                        0.000
  PR interval (ms)                    143 ± 16      143 ± 21        145 ± 13                         0.76
  QRS interval (ms)                   86 ± 10       89 ± 11         90 ± 13                          0.005
  QRS axis (°)                        68 ± 25       67 ± 27         58 ± 26                          0.9
  T axis (°)                          58 ± 18       55 ± 20         56 ± 7.5                         0.19
  P axis (°)                          56 ± 25       56 ± 26         65 ± 10                          0.97
  P wave duration (ms)                94 ± 12       94 ± 12         98 ± 10                          0.8
  QRS amplitude DII (mV)              1.6 ± 0.4     1.4 ± 0.4       1.4 ± 0.7                        0.000
  P wave amplitude DII (mV)           0.14 ± 0.05   0.15 ± 0.05     0.160.04                         0.2
  T wave amplitude DII (mV)           0.48 ± 0.17   0.39 ± 0.18     0.32 ± 0.11                      0.000
  QT interval DII or V5 (ms)          389 ± 48      370 ± 27        366 ± 40                         0.000
  QT interval V2 or V3 (ms)           383 ± 38      370 ± 35        367 ± 37                         0.001
  Fridericia c-QT DII or V5 (ms)      405 ± 20      405 ± 27        394 ± 31                         0.9
  Fridericia c-QT V2 or V3 (ms)       403 ± 35      405 ± 37        396 ± 24                         0.6
  Framingham c-QT DII or V5 (ms)      405 ± 20      405 ± 27        394 ± 28                         0.6
  Framingham c-QT V2 or V3 (ms)       404 ± 33      404 ± 31        396 ± 24                         0.8
  T~peak~-T~end~ DII or V5 (ms)       88 ± 9        85 ± 10         82 ± 12                          0.007
  T~peak~-T~end~ V2 or V3 (ms)        103 ± 14      97 ± 14         95 ± 12                          0.000
  T~peak~-T~end~/QT V2 or V3 ratio    0.26 ± 0.03   0.26 ± 0.07     0.25 ± 0.03                      0.8
  T~peak~-T~end~/QT Dii or V5 ratio   0.22 ± 0.02   0.23 ± 0.02     0.22 ± 0.02                      0.4

**Note:**

*P* value calculated between ERP group and control group.

**Abbreviations:** BP, blood pressure; c-QT, corrected QT interval; ECG, electrocardiogram; ERP, early repolarization pattern.

###### 

Comparison of the prevalence of Brugada-type ECG in different ethnic populations

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                      Year of publication   Origin                N         Males (%)   Age (years)   Nature of population                        Sex ratio of BS M/F   Prevalence of BS Type 1 (%)   Prevalence of all BS types (%)   FU                  Sudden death during FU
  ------------------------------------------ --------------------- --------------------- --------- ----------- ------------- ------------------------------------------- --------------------- ----------------------------- -------------------------------- ------------------- ---------------------------------------
  **Asian population**                                                                                                                                                                                                                                                            

  Furuhashi et al[@b11-oajsm-2-033]          2001                  Japan                 8612      69.5        49.2\         Health examination                          11/1                  0.05                          0.14                             NA                  NA
                                                                                                               (22--84)                                                                                                                                                           

  Mastuo et al[@b12-oajsm-2-033]             2001                  Japan                 4788      40.8        45 ± 10.5     Health examination                          27/5                  NA                            0.14                             41 years            5

  Atarashi et al[@b13-oajsm-2-033]           2001                  Japan                 10,000    89.1        42 ± 9        Health examination                          16/0                  NA                            0.16                             NA                  NA

  Yamakawa et al[@b14-oajsm-2-033]           2004                  Japan                 20,387    51.1        9.7 ± 3.2     School children                             1/1                   0.0049                        0.0098                           NA                  NA

  Yoshinaga et al[@b15-oajsm-2-033]          2004                  Japan                 7022      100         15            Male adolescents                            7                     0.06                          0.1                              NA                  NA

  Oe etal[@b16-oajsm-2-033]                  2005                  Japan                 21,944    41.4        6--7          Children, CBP                               2/2                   0.005                         0.02                             6.8 ± 1 years       0

  Babaee Bigi et al[@b17-oajsm-2-033]        2007                  Iran                  3895      46          38.2 ± 11.9   Tertiary hospital                           66/44                 0.54                          2.56                             NA                  NA

  Gervacio-Domingo et al[@b18-oajsm-2-033]   2008                  Philippines           3907      NA          ≥20           Healthy subjects                            68/26                 0.2                           2.1                              NA                  NA

  Wajed et al[@b19-oajsm-2-033]              2008                  Pakistan              1100      64.7        NA            Healthy young students                      7/2                   NA                            0.8                              NA                  NA

  Tsuji et al[@b20-oajsm-2-033]              2008                  Japan                 13,904    26          58 ± 10       Health examination                          80/18                 0.26                          0.7                              7.8 ± 1.6 years     1

  Sidik et al[@b21-oajsm-2-033]              2009                  China(br/)Singapore   392       55.9        49.9 ± 19.1   Tertiary medical center                     27/1                  4.8                           7.1                              30.4 person-years   0

  **European population**                                                                                                                                                                                                                                                         

  Hermida et al[@b22-oajsm-2-033]            2000                  France                1000      63.2        39 ± 10       Normal subjects                             52/9                  0.1                           0.61                             49 ± 30 months      0

  Viskin et al[@b23-oajsm-2-033]             2000                  Israel                592       58.4        36 ± 10       Tertiary hospital                           NA                    0                                                              NA                  NA

  Bianco et al[@b24-oajsm-2-033]             2001                  Italy                 155       100%        30.9 ± 10.1   Competitive athletes                        12                    7.7                           NA                               NA                  NA

  Junttila et al[@b25-oajsm-2-033]           2004                  Finland               2749      100%        18--30        Finnish air force                           NA                    0                             0.61                             19 ± 2 years        0

  Blangy et al[@b26-oajsm-2-033]             2005                  France                35,309    47%         37.2          Health examination                          14/6                  0.016                         0.05                             30 months           0

  Bozkurt et al[@b27-oajsm-2-033]            2006                  Turkey                1238      77.8%       38.9 ± 17.6   Tertiary hospital and university students   5/1                   0.08                          0.48                             NA                  NA

  Letsas et al[@b28-oajsm-2-033]             2007                  Greece                11,488    57.7%       15--98        Tertiary hospital                           23/2                  0.02                          0.22                             24 ± 12 months      0

  Gallagher et al[@b29-oajsm-2-033]          2008                  Italy                 12,012    90.8%       29 ± 9        Healthy subjects                            23/0                  0.016                         0.19                             10.1 ± 5.5 years    1 patient/0.3% per patient of year FU

  Sinner et al[@b30-oajsm-2-033]             2009                  German                4149      49%         50.6 ± 13.9   General population                          0                     0                             0                                NA                  NA

  **American population**                                                                                                                                                                                                                                                         

  Monroe and Littman[@b31-oajsm-2-033]       2000                  USA                   12,000    NA          NA            Urban teaching hospital                     NA                    0.016                         0.43                             NA                  NA

  Greer and Glancy[@b32-oajsm-2-033]         2003                  USA                   27,328    NA          NA            Medical center                              NA                    0                             0.065                            NA                  NA

  Donohue and [@b33-oajsm-2-033]             2008                  USA                   1348      NA          52.7 ± 16.2   Tertiary hospital                           1/1                   0                             0.14                             NA                  NA

  Patel et al[@b34-oajsm-2-033]              2009                  USA                   162,590   NA          NA            Tertiary medical center                     13/7                  0.005                         0.012                            NA                  NA

  **North African population**                                                                                                                                                                                                                                                    

  This study                                 2010                  Tunisia               540       348         18.3 ± 2.4    Athletes                                    7/2                   0                             1.16                             NA                  NA
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** BS, Brugada sign; FU, follow-up; F, female; M, male; NA, not available; CBP, community-based population.
